Home › Metastatic Cancer › Missouri › Kansas City

Pag-aaral pangklinika para sa Metastatic Cancer sa Kansas City, MO

Isang pag-aaral para sa Metastatic Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Kansas City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Nagre-recruitPhase 1

St. Lukes Hospital of Kansas City, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06625775

A Study of ASP3082 in Adults With Advanced Solid Tumors

Nagre-recruitPhase 1

University of Kansas Medical Center, Westwood · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT05382559

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Nagre-recruitPhase 1

University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05803382

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

University of Kansas Medical Center, Westwood · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05875168

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Nagre-recruitPhase 2/3

Premier Imaging, Kansas City
St. Joseph Medical Center, Kansas City
MidAmerica Cancer Care - American Oncology Partners, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06989437

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

Nagre-recruitPhase 1

The University of Kansas Medical Center, Westwood · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06915753

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Nagre-recruitPhase 3

HCA Midwest Kansas City, MidAmerica Division, Inc., Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213804

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Nagre-recruitPhase 3

Saint Luke's Cancer Institute, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07174336

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Nagre-recruitPhase 3

The University of Kansas Cancer Center - Westwood, Westwood · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Nagre-recruitPhase 1/2

University of Kansas Cancer Center - North, Kansas City
University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT05691491

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Nagre-recruitPhase 3

University of Kansas Cancer Center - North, Kansas City
University of Kansas Cancer Center, Westwood · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT06216301

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Nagre-recruitPhase 3

Saint Luke's Cancer Institute, Kansas City
The University of Kansas Cancer Center, Westwood · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT06757634

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

Nagre-recruitPhase 2/3

MidAmerica Cancer Care, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update May 8, 2026 · NCT06697301

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Nagre-recruitPhase 3

University of Kansas Cancer Center, Westwood · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 9, 2026 · NCT06064877

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Kansas City

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Metastatic Cancer sa ibang lungsod

Iba pang pag-aaral sa Kansas City

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.